RS

Rammi Sharma

Active Director Designated Partner DIN 10387997
DIN 10387997 First appointment Nov 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Rammi Sharma

Data last updated:

Rammi Sharma is a Designated Partner at Nabiqo Pharma Llp (since 2023). The company operates in Paper.

DIN 10387997
Primary Designation Designated Partner
Industry Paper
First Appointment 09 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Nov 20232023Active

Board colleagues of Rammi Sharma

NameDINCompanyDesignation
Bashir Mohammed10387996Nabiqo Pharma LlpDesignated Partner
Mustaq Lalmohammad Choudhary10387999Nabiqo Pharma LlpDesignated Partner
Preeti Sunilkumar Soni10387998Nabiqo Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Nabiqo Pharma Llp
Premium access

Shareholding and investment profile for Rammi Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rammi Sharma

Rammi Sharma currently holds 1 directorship: Nabiqo Pharma Llp (Designated Partner, since 09 Nov 2023).

Rammi Sharma was first appointed on 09 Nov 2023 as Designated Partner at Nabiqo Pharma Llp.

The current boards of Rammi Sharma's companies include Bashir Mohammed (Nabiqo Pharma Llp), Mustaq Lalmohammad Choudhary (Nabiqo Pharma Llp), Preeti Sunilkumar Soni (Nabiqo Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available